Telemedicine takes on lymphoma: a 350-Patient trial

NCT ID NCT03336138

Completed Knowledge-focused Sponsor: University Hospital, Toulouse Source: ClinicalTrials.gov ↗

First seen Jan 04, 2026 · Last updated Jun 12, 2026 · Updated 24 times

Summary

This study looked at whether using telemedicine (remote doctor visits) can improve how aggressive lymphomas are managed. The main goal was to see if patients got the right amount of chemotherapy on time. 350 patients from 10 hospitals took part. The study compared telemedicine support to usual care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Bayonne Hospital

Bayonne, 64000, France
Clinique Claude Bernard

Albi, 81000, France
Clinique Marzet

Pau, 64000, France
Clinique Saint Jean

Toulouse, 31000, France
Hospital

Auch, 32000, France
Hospital

Montauban, 82000, France
Rodez Hospital

Rodez, 12000, France
Tarbes Hospital

Tarbes, 65000, France
University Hospital Bordeaux

Bordeaux, 33000, France
University Hospital of Toulouse

Toulouse, France, France

Conditions

Explore the condition pages connected to this study.

LYMPHOMA